Acute Respiratory Distress Syndrome Therapeutics Market Report

Global and Region Acute Respiratory Distress Syndrome Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：154
  • REPORT CODE：GMM970666
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Acute Respiratory Distress Syndrome Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Respiratory Distress Syndrome Therapeuticsmarket, defines the market attractiveness level of Acute Respiratory Distress Syndrome Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Acute Respiratory Distress Syndrome Therapeutics industry, describes the types of Acute Respiratory Distress Syndrome Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Respiratory Distress Syndrome Therapeutics market and the development prospects and opportunities of Acute Respiratory Distress Syndrome Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Respiratory Distress Syndrome Therapeutics market in Chapter 13.

    By Player:

    • FirstString Research, Inc

    • Athersys, Inc

    • Faron Pharmaceuticals Oy

    • Therabron Therapeutics, Inc

    • Altor BioScience Corporation

    • Phylogica Limited

    • GlaxoSmithKline Plc

    • Serendex Pharmaceuticals A/S

    • Histocell SL

    • Silence Therapeutics Plc

    By Type:

    • Methylprednisolone

    • Hydrocortisone

    • Calf Pulmonary Surfactant for Injection

    • Others

    By End-User:

    • In-Patient

    • Out-Patient

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Acute Respiratory Distress Syndrome Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Acute Respiratory Distress Syndrome Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Acute Respiratory Distress Syndrome Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Acute Respiratory Distress Syndrome Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Acute Respiratory Distress Syndrome Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.2 United States Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.3 Europe Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.4 China Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.5 Japan Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.6 India Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Acute Respiratory Distress Syndrome Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Acute Respiratory Distress Syndrome Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2022-2028)

    9 Global Acute Respiratory Distress Syndrome Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Methylprednisolone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hydrocortisone Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Calf Pulmonary Surfactant for Injection Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global In-Patient Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Out-Patient Consumption and Growth Rate (2017-2022)

    10 Global Acute Respiratory Distress Syndrome Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Methylprednisolone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Hydrocortisone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Calf Pulmonary Surfactant for Injection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global In-Patient Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Out-Patient Consumption Forecast and Growth Rate (2022-2028)

    11 Global Acute Respiratory Distress Syndrome Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Acute Respiratory Distress Syndrome Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Acute Respiratory Distress Syndrome Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Acute Respiratory Distress Syndrome Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Acute Respiratory Distress Syndrome Therapeutics Market Competitive Analysis

    • 14.1 FirstString Research, Inc

      • 14.1.1 FirstString Research, Inc Company Details

      • 14.1.2 FirstString Research, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 FirstString Research, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.2 Athersys, Inc

      • 14.2.1 Athersys, Inc Company Details

      • 14.2.2 Athersys, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Athersys, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.3 Faron Pharmaceuticals Oy

      • 14.3.1 Faron Pharmaceuticals Oy Company Details

      • 14.3.2 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.4 Therabron Therapeutics, Inc

      • 14.4.1 Therabron Therapeutics, Inc Company Details

      • 14.4.2 Therabron Therapeutics, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Therabron Therapeutics, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.5 Altor BioScience Corporation

      • 14.5.1 Altor BioScience Corporation Company Details

      • 14.5.2 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.6 Phylogica Limited

      • 14.6.1 Phylogica Limited Company Details

      • 14.6.2 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.7 GlaxoSmithKline Plc

      • 14.7.1 GlaxoSmithKline Plc Company Details

      • 14.7.2 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.8 Serendex Pharmaceuticals A/S

      • 14.8.1 Serendex Pharmaceuticals A/S Company Details

      • 14.8.2 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.9 Histocell SL

      • 14.9.1 Histocell SL Company Details

      • 14.9.2 Histocell SL Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Histocell SL Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • 14.10 Silence Therapeutics Plc

      • 14.10.1 Silence Therapeutics Plc Company Details

      • 14.10.2 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Acute Respiratory Distress Syndrome Therapeutics

    • Figure Acute Respiratory Distress Syndrome Therapeutics Picture

    • Table Global Acute Respiratory Distress Syndrome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Acute Respiratory Distress Syndrome Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Acute Respiratory Distress Syndrome Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Country (2017-2022)

    • Figure United States Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Acute Respiratory Distress Syndrome Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Methylprednisolone Consumption and Growth Rate (2017-2022)

    • Figure Global Hydrocortisone Consumption and Growth Rate (2017-2022)

    • Figure Global Calf Pulmonary Surfactant for Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global In-Patient Consumption and Growth Rate (2017-2022)

    • Figure Global Out-Patient Consumption and Growth Rate (2017-2022)

    • Figure Global Methylprednisolone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hydrocortisone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Calf Pulmonary Surfactant for Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global In-Patient Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Out-Patient Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Acute Respiratory Distress Syndrome Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Acute Respiratory Distress Syndrome Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table FirstString Research, Inc (Foundation Year, Company Profile and etc.)

    • Table FirstString Research, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table FirstString Research, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Athersys, Inc (Foundation Year, Company Profile and etc.)

    • Table Athersys, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Athersys, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Faron Pharmaceuticals Oy (Foundation Year, Company Profile and etc.)

    • Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Therabron Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Therabron Therapeutics, Inc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Therabron Therapeutics, Inc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Altor BioScience Corporation (Foundation Year, Company Profile and etc.)

    • Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Phylogica Limited (Foundation Year, Company Profile and etc.)

    • Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Serendex Pharmaceuticals A/S (Foundation Year, Company Profile and etc.)

    • Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Histocell SL (Foundation Year, Company Profile and etc.)

    • Table Histocell SL Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Histocell SL Acute Respiratory Distress Syndrome Therapeutics Product and Service

    • Table Silence Therapeutics Plc (Foundation Year, Company Profile and etc.)

    • Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US